Atheroemboli to the brain: Size threshold for causing acute neuronal cell death  by Rapp, Joseph H. et al.
68
Our current concepts linking stroke to cerebral
emboli from carotid bifurcation atherosclerosis origi-
nate from observations of emboli in the microcircula-
tion of the retina. Hollenhorst1 found an association
between transient monocular blindness and the
appearance of cholesterol crystals in the retinal micro-
circulation and reasoned that these crystals represent-
ed emboli from proximal atherosclerotic vessels.
Other investigators demonstrated that cholesterol was
not the only material found in these emboli to the
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Objective: The objective of this study was to investigate the dilemma posed by the obser-
vations that carotid angioplasty dislodges significant numbers of plaque fragments but
is reported to have a low rate of neurologic consequences. We examined the fragments
released by ex vivo carotid angioplasty. The smaller and most numerous were separated
by size and injected into rats to determine the tolerance of the brain to microemboli.
Methods: Ex vivo angioplasty was performed on a total of 20 human carotid plaques
removed en bloc. Plaques were placed within polytetrafluoroethylene grafts, and three
manipulations were performed: guide wire insertion, 3.5- or 4.0-mm balloon angio-
plasty, and 5-mm angioplasty with or without a Palmaz stent. After each manipulation,
the lumen was flushed, effluent was collected, and fragments were counted under 100×
magnification. Using 200-µm and 500-µm micropore mesh, we separated fragments by
size into two groups: (1) less than 200 µm and (2) 200 to 500 µm. We then injected
rats with saline alone (Group A), with 100 fragments less than 200 µm (Group B), or
with 100 fragments 200 to 500 µm (Group C). Animals were euthanized at 1, 3, and
7 days, and brain sections were examined for cell viability and expression of HSP-
72.
Results: The total number of fragments dislodged from the plaques varied from 30 to
553. The mean number of fragments released with each manipulation was as follows:
guide wire passage, 24; initial balloon angioplasty, 97; second balloon angioplasty, 68;
and second angioplasty plus stent, 172. Sixteen of the 20 plaques dislodged fragments
that were 1 mm or more in greatest dimension. There was no evidence of brain ischemia
in Group A at any time. Group B also showed no injury at 1 or 3 days. However, injec-
tion of 200- to 500-µm fragments (Group C) caused a scattered pattern of neuronal cell
death. At 7 days, brain sections from both Group B and Group C animals had a scat-
tered pattern of ischemic neurons. There were no classic wedge-shaped infarctions.
Discussion: The brain appears to have a surprising tolerance for microembolization in the
acute setting. Thus, carotid angioplasty may dislodge plaque fragments, but there may
still be a low incidence of stroke. However, even small plaque fragments, less than 200
µm, may cause neuronal ischemia at later time points. Periprocedural microemboli could
cause subtle neurologic dysfunction in late follow-up. (J Vasc Surg 2000;32:68-76.)
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retina. They found other materials, including
platelets, leukocytes, and “lipid material”2,3 in the
lesions occluding the retinal vessels in patients with
monocular blindness. Several of these early investiga-
tors noted the association of carotid stenosis and
luminal surface irregularity with the transient clinical
events, but Ehrenfeld et al4 demonstrated that symp-
toms stopped after surgical removal of ulcerated
plaques at the carotid bifurcation. Shortly thereafter,
Moore and Hall5 showed that hemispheric symptoms
also ceased with the removal of ipsilateral ulcerated
internal carotid plaques.
But embolization to the retina can be seen with-
out any clinical sequelae.6 With the introduction of
the transcranial Doppler sonography (TCD), it is
now recognized that asymptomatic embolization in
the distribution of the middle cerebral artery is also
commonplace.7-10 During carotid surgery or angio-
plasty, hundreds of embolic signals may be detected
without apparent clinical significance.11,12 Jansen et
al13 found new “silent” lesions on brain magnetic
resonance imaging with higher numbers of TCD-
detected embolic signals during carotid surgery. If
these TCD signals actually represent particulates,
the brain appears to have an impressive tolerance to
microemboli; random monitoring with TCD indi-
cates that patients with more frequent emboli may
have a higher rate of stroke.14,15 More subtle signs
of damage have also been associated with high num-
bers of TCD-detected embolic signals. Pugsley et
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al11 found that with more than 1000 embolic signals
detected during cardiopulmonary bypass grafting,
43% of patients had measurable neuropsychological
deficits, although no patient had a focal neurologic
event. These cognitive deficits were not transient
and became even more pronounced when the
patients were tested again, 8 weeks after surgery.
Clarifying the frequency and importance of cere-
bral microemboli has particular significance now.
The number of carotid endarterectomies is increas-
ing,16 and carotid angioplasty is being proposed as
an alternative to carotid endarterectomy. The indica-
tion for both procedures is prevention of stroke, yet
plaque fragments may be dislodged with both pro-
cedures.12,17 We believe that although the rate of
focal neurologic deficits with endarterectomy is
quite low18,19 and several authors report that similar
results can be achieved with angioplasty,20,21 the
potential acute and chronic effects of periprocedural
microemboli are cause for concern.
In the current study we set out to determine the
size and number of plaque fragments released with ex
vivo balloon angioplasty of human carotid plaques.
After the neurointerventional in vivo protocol, we
determined the number and size of particlulates
released with each procedural step. Because the num-
ber of particulates was as high as suggested by TCD
during in vivo procedures, we then turned to a rat
model of cerebral injury to determine if these partic-
ulates were likely to cause neuronal injury.
Fig 1. The number and size of plaque fragments released with ex vivo angioplasty. Data are expressed
as the mean ± SD.
hours, and three were done more than 72 hours
after the surgical removal. All specimens were stored
in saline at 4°C.
Angioplasties were performed at 37°C. Each
wrapped specimen was flushed with 10 mL of saline,
and the effluent was discarded. Angioplasty was per-
formed twice on each specimen. In four specimens,
a 0.0018-in guide wire was initially inserted through
the specimen, and in 16 specimens the initial angio-
plasty catheter had a leading guide wire attached,
which did not allow collection of a separate sample
after guide wire passage alone. The initial angioplas-
ty was done with a 3.5- or 4.0-mm balloon (Cordis
Endovascular, Warren, NJ) depending on vessel size.
The second angioplasty was performed with a 5-mm
balloon. Two inflations of 30 seconds at 15 atm
were done for both the first and second angioplasty.
In seven specimens Palmaz stents were deployed by
placing them on the angioplasty balloon (Cordis
Endovascular) before the second angioplasty.
Collection and analysis of embolic fragments.
The specimens were flushed × 2 with 10 mL of
saline, and the effluent was collected in 20-mL con-
ical centrifuge tubes after each manipulation. The
effluent was centrifuged at 20,000g for 20 minutes,
the saline was decanted, and the particulates were
resuspended in 500 µL of fresh saline. The number
and size of embolic fragments in the effluent were
examined under a microscope at 100× magnification
with a 100-µm background grid. Fragments were
categorized in increments of 100 µm according to
their maximum dimension (Fig 2). Fragments under
100 µm were not counted.
For the animal experiments, the fragments were
separated into suspensions containing fragments less
than 200 µm and fragments 200 to 500 µm in great-
est dimension. Effluent from plaque angioplasty
experiments was sequentially sieved through 200-
and then 500-µm micropore mesh (Spectrum Lab,
Laguna Hills, Calif). This resulted in two prepara-
tions of particles: one containing particulates less
than 200 µm in maximum diameter and another
containing particulates 200 to 500 µm in maximum
diameter. Each preparation was centrifuged, and all
particulates greater than 100 µm were counted,
resuspended in saline and then divided into 300-µL
portions, which had a final concentration of 100
fragments per portion.
Cerebral embolization in rats. All procedures
were approved by the Animal Care Committee of
the San Francisco DVA Medical Center. Male
Sprague-Dawley rats (Simonsen Laboratories,
Gilroy, Calif) that weighed 350 to 450 g were divid-
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METHODS
Carotid endarterectomy specimens. Twenty
carotid bifurcation endarterectomy specimens were
obtained from patients undergoing elective carotid
endarterectomy at one of the participating institu-
tions. Sixteen specimens were removed en bloc and
four by eversion endarterectomy. All had stenoses >
60%. The stenoses in 14 of the 20 specimens were >
80%. Each specimen was kept circumferentially
intact during the surgical removal.
Before angioplasty, the external carotid artery
(ECA) plaque was ligated at its origin with 3-0 silk
suture, and any plaque extending beyond the tie was
removed. A 2-cm length of 18-French latex tubing
was inserted into the proximal stump and fixed in
place with adhesive. Polytetrafluoroethylene (PTFE)
vascular grafts with 6-, 8-, or 10-mm diameters (W.
L. Gore and Associates, Inc, Phoenix, Ariz) were cut
open longitudinally, and their outer reinforcing
wraps were removed. After the graft was carefully
trimmed to fit the contour of the specimen, the
specimen was blotted dry, dotted with adhesive, and
placed into the lumen of the graft. The graft was
then sutured closed with a C-V 7 suture (W. L. Gore
and Associates), and the suture line was coated with
adhesive.
Ex vivo angioplasty. Ex vivo angioplasty was
performed immediately after the endarterectomy on
10 specimens. Four angioplasties were done within
24 hours of removal, three were done within 72
Fig 2. Atherosclerotic fragments from a single balloon
angioplasty with a 5.0-mm balloon. The fragments are
shown as photographed at the bottom of a glass beaker.
ed into three groups: Group A (n = 9) rats received
injections of 300 µL of saline alone; Group B (n =
9) rats received injections of 300 µL of saline con-
taining 100 atherosclerotic fragments that were 100
to 200 µm in greatest dimension; and Group C rats
received injections of 300 µL of saline containing
100 atherosclerotic fragments that were 200 to 500
µm in greatest dimension.
All rats were anesthetized with 100 mg/kg of
ketamine hydrochloride and 10 mg/kg of xylazine
intraperitoneal. Under the operating microscope,
the right common carotid artery, the internal carotid
artery (ICA), and the ECA were exposed through a
midline incision in the neck. The ICA was carefully
separated from the vagus nerve, and the ptery-
gopalatine artery was identified at the base of the
skull. This posteriorly directed extracranial branch of
the ICA was ligated with 7-0 suture near its origin
to ensure that all the particles injected into the ICA
would go to the brain. The ECA was dissected fur-
ther distally; the occipital artery and superior thyroid
artery were dissected and ligated. A temporary
microvascular clip was then applied on the ECA just
above its origin. Once the artery was prepared, PE-
50 tubing was inserted retrograde into the ECA
through a transverse arteriotomy, the microvascular
clip was removed, and the tubing tip was positioned
near the origin of the ICA. The common carotid
artery was then temporarily occluded with an encir-
cling 4-0 silk suture. The atherosclerotic fragment
containing saline was then injected slowly (3-5 sec-
onds). After the injection of saline, with or without
atheroemboli, the 4-0 silk suture was removed, the
ECA was ligated, and the wound was closed.
Identification of heat shock protein 72 in the
rat brain. We examined brain tissue for injured neu-
rons by assaying for heat shock protein 72 (HSP72)
using a Western blot technique. The HSPs are mas-
sively induced after heat shock or ischemia and are
sensitive markers of cell injury.22-24
Rats were euthanized 24 hours, 48 hours, or 7
days after embolization. Under anesthesia, the
abdomen was opened, and the aorta was cannulated.
Rats were given heparin (100 U/Kg) and perfused
with 100 mL of 0.9% saline, followed by 500 mL of
4.0% paraformaldehyde in 0.1 mol/L phosphate
buffer, pH 7.4 phosphate-buffered saline (PBS).
The brains were removed from the cranial vault and
postfixed in paraformaldehyde and PBS for 2 to 4
hours. Coronal sections (100 µm) were cut on a
vibratome and placed in PBS overnight.
Immunocytohistochemistry was performed using
the avidin-biotin/horseradish peroxidase technique.
Sections were placed in PBS containing 2% horse
serum, 0.2% Triton X-100, and 0.1% bovine serum
albumin (horse serum–phosphate-buffered saline
[HS-PBS]) for 2 hours at room temperature. They
were then incubated for 72 hours at 4°C in the pri-
mary monoclonal antibody to HSP72 (Amersham,
Arlington Heights, Ill), which was diluted 1:4000 in
HS-PBS. Sections were then washed in PBS, incubat-
ed for 2 hours in biotinylated horse antimouse second
antibody, and incubated for 2 hours in the avidin-
horseradish peroxidase solution prepared from the
Elite ABC Kit (Vectastain, Vector Laboratories,
Burlingame, Calif). Sections were washed in PBS and
reacted for horseradish peroxidase using diaminoben-
zidine (0.04% in PBS) and 0.3% hydrogen peroxide.
Reacted sections were then washed, kept in PBS
overnight, and mounted on gelatinized slides.
Sections were processed as described above to deter-
mine nonspecific binding, except that first the anti-
body was deleted.
Identification of NeuN staining. Brain sec-
tions were also processed with the avidin-
biotin/horseradish peroxidase technique for staining
with a monoclonal antibody to the neuron-specific
protein NeuN. Lack of staining with antibody to
NeuN suggests nonviability of neuronal cells.
RESULTS
Fragments released during angioplasty. The
number and size of fragments released during each
manipulation is shown in Fig 1. Advancing the guide
wire through the lesion caused a small number of
fragments to be dislodged in each of the four speci-
mens in which a guide wire was inserted as done as
a separate procedure. Most were less than 200 µm in
greatest dimension, although in one case, a fragment
greater than 900 µm was retrieved after guide wire
insertion.
With each balloon angioplasty the PTFE “adven-
titia” distended noticeably. This would often occur
suddenly, presumably indicating the moment of
plaque fracture. There was substantial variation in
the number of fragments released with each balloon
dilation, ranging from 11 to 323. When angioplasty
resulted in a greater amount of plaque material to be
released, this generally included a greater number of
both small and large fragments, although the relative
number of large and small fragments released was
not consistent among the specimens. Often, the
number of fragments recovered with the initial
angioplasty was similar to the number recovered
after the second angioplasty, suggesting that plaque
architecture was the determining factor in the
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amount of material dislodged rather than the size of
the angioplasty balloon (Table I).
In the seven cases in which we deployed a
Palmaz stent with the 5-mm angioplasty balloon,
the number of fragments recovered was not reduced
compared with the number of fragments recovered
after angioplasty alone. We had hypothesized that
the stent structure would hold the plaque in place
and reduce the number of fragments released into
the lumen. If any trend was to be seen, it appeared
that there were more fragments released with stent
placement, although this most likely represents the
assignment of plaques that were more prone to frag-
mentation to the stented group (Table I, Fig 1).
Effect of storage on fragmentation of the
plaque. There appeared to be no effect on the num-
ber of fragments released and on the time from sur-
gical removal to ex vivo angioplasty. The plaques
that released the largest number of fragments under-
went angioplasty within 24 hours of surgical
removal. This counter intuitive observation is prob-
ably best explained by variation in plaque architec-
ture rather than a propensity for fresh plaque speci-
mens to fragment more easily than stored specimens.
HSP72 production after embolization (Table
II). The animals injected with saline alone (Group
A) had no evidence of cerebral injury at any time
point. After injection of fragments that had traversed
the 200-µm mesh (Group B), there was no evidence
of injury in the rats euthanized and examined 1 and
3 days after injection. Staining with NeuN in these
slices showed viable neurons. However, there was
evidence of injury in two of the three Group B rats
humanely killed 7 days after injection. The injury
was scattered but detectable both by HSP72 
production and the lack of NeuN staining in those
neurons.
In contrast, after Group C animals were injected
with 200- to 500-µm fragments, damaged neurons
could easily be detected 1 day after injection in all
three animals. At 3 days only one of the three ani-
mals was positive for injury. The cumulative data for
these early time points were four of six animal brain
slices stained positive for neurologic injury. At 7 days
two of the three animals injected with 200- to 500-
µm fragments were positive for ischemic injury. In
all cases the injuries were scattered. As in the Group
B animals, the blots for HSP72 reciprocated the
findings of the blots for NeuN (Table II). The
ischemic injury did not coalesce into a segmental
defect in any of the animals.
DISCUSSION
An abundance of clinical and experimental data
has shown that emboli from carotid bifurcation ath-
erosclerosis are a major cause of neuronal injury and
clinical stroke. Yet we found no evidence of acute
neuronal injury at 1 and 3 days after injecting
atheosclerotic plaque fragments up to 200 µm in
greatest dimension, a range of particle sizes expected
to occlude arterioles. The complete absence of neu-
ronal injury at these early time points was unexpect-
ed. Our hypothesis had been that these particulates
would cause at least a diffuse pattern of injury.
Arterioles in the 50- to 300-mm range should have
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Table II. Results of HSP72 and NeuN
Results
# Size of embolus Period HSP Neun
1 0-200 µm 1 d – +
2 0-200 µm 1 d – +
3 0-200 µm 1 d – +
4 0-200 µm 3 d – +
5 0-200 µm 3 d – +
6 0-200 µm 3 d – +
7 0-200 µm 7 d + –
8 0-200 µm 7 d + –
9 0-200 µm 7 d – +
1 200-500 µm 1 d + –
2 200-500 µm 1 d + –
3 200-500 µm 1 d + –
4 200-500 µm 3 d – +
5 200-500 µm 3 d + –
6 200-500 µm 3 d – +
7 200-500 µm 7 d + –
8 200-500 µm 7 d + –
9 200-500 µm 7 d – +
A negative value represents no staining seen with any section.
Conversely, any positive staining was noted (see text).
Table I. Fragments released after ex vivo angioplasty
Manipulation > 100 µm > 200 µm > 300 µm > 400 µm > 500 µm
Guide wire (n = 4) 12.8 ± 9.9 6.3 ± 7.6 2.5 ± 3.1 1.5 ± 2.4 0.3 ± 0.5
First balloon (n = 20) 50.7 ± 41.1 22.3 ± 20.7 9.1 ± 7.6 4.1 ± 4.4 2.8 ± 2.6
Second balloon (n = 13) 37.0 ± 43.1 13.8 ± 12.5 7.4 ± 6.7 3.4 ± 3.0 1.8 ± 1.6
Second balloon + stent (n = 7) 94.4 ± 59.8 41.4 ± 28.7 14.7 ± 8.2 6.9 ± 4.1 5.0 ± 2.8
been significantly narrowed if not occluded by these
plaque fragments. Our predictions were not purely
speculative, because occlusion of vessels in the 50- to
300-µm diameter range are associated with “border
zone” infarctions in human brains examined after
stroke.25 Our data suggest that while the mechanism
is not clear, the mammalian brain has a surprising
tolerance to this size range of atheroemboli.
There are other experimental data demonstrating
tolerance of the brain to microemboli. Heistad et
al26 injected 15-µm microspheres into dog carotid
arteries at a dose of 400 microspheres per gram
brain without effect. They then repeated this injec-
tion 25 times without observing hemodynamic
changes or gross neurologic findings in these ani-
mals. However, when the investigators injected 50-
µm microspheres, they did precipitate alterations in
brain blood flow and observable neurologic deficits
with a single dose. In our experiments we injected
approximately 50 atheroemboli per gram brain.
Presumably a higher dose of atheroemboli would
have produced a neurologic injury. Although our
atheroemboli were larger than 50 µm in maximal
dimension, they were irregular in shape and compo-
sition (Fig 1). Compared with microspheres, these
particulates may be less likely to occlude the micro-
circulation and precipitate acute neuronal ischemia.
In contrast, after the injection of the larger, 200-
to 500-µm atherosclerotic fragments, there was neu-
ronal injury at both the 1 and 3 day time points. But
even with these larger fragments, the injury was scat-
tered and never coalesced to create a segmental cere-
bral infarction. The rat model of brain ischemia has
been shown to develop consistent patterns of cere-
bral infarction after fragmented thrombus injection
by several investigators including one of our coau-
thors (FRS) in whose laboratory these experiments
were performed.27-30 The total volume of thrombus
injected in these reports appears consistent with our
experimental protocol. However, fragments of
thrombus, like microspheres, may be more likely to
occlude the microcirculation than our atheroembol-
ic material. Additional experiments will be required
to address this issue.
By 7 days after injection there was evidence of
ischemic injury in the animals injected with frag-
ments less than 200 µm as well as those injected with
fragments that were 200 to 500 µm. Atheroemboli
induce an intra-arterial inflammatory reaction that
leads to scarring and late vascular occlusions.31,32
The response begins within 24 hours with monocyte
accumulation, and by 4 days the reaction includes
both endothelial proliferation and intravascular fibro-
sis that can persist for several weeks.33,34 These data
emphasize the importance of late time points in eval-
uating the true significance of atheroemboli. This
late fibrotic reaction to atheroembolization is seen in
all tissues, including the brain.25 Pugsley et al11
examined patients with neuropsychological deficits
detected 8 days after cardiac surgery and routinely
found further deterioration when these patients were
reexamined 8 weeks later, suggesting an extension of
the injury. Unfortunately, in our experimental proto-
col, cross-species immune response could have been
a confounding factor, amplifying the inflammatory
response to the atheroemboli. Further experiments
in athymic rats may help define the amount of
inflammation due to immune response in this model.
Because the average adult human brain weighs
1300 g and the rat brain weighs only 2 g, the equiv-
alent number of emboli dislodged from a human
ICA would be approximately 65,000. This number
seems preposterous for rates of periprocedural
emboli, yet human brains may be subjected to very
high numbers of microemboli over time. Random
monitoring of patients with known carotid athero-
sclerotic lesions with TCD has recorded more than
70 High Intensity Signals (HITS) in a 30-minute
monitoring session.7 If that rate should persist, it
would take only 19 months for this “asymptomatic”
carotid lesion to have shed 65,000 emboli in the dis-
tribution of the middle cerebral artery.
Every maneuver we performed released atheroscle-
rotic debris, including simply passing the guide wire
through the lesion. Our findings are consistent with
reported clinical observations in which numerous
embolic phenomena recorded by TCD during carotid
angioplasty are described. The number of embolic sig-
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> 600 µm > 700 µm > 800 µm > 900 µm > 1 mm > 2 mm > 3 mm Total
0.3 ± 0.5 0.3 ± 0.5 0.0 ± 0.0 0.0 ± 0.0 0.3 ± 0.5 0.0 ± 0.0 0.0 ± 0.0 23.8 ± 23.9
1.8 ± 2.0 1.3 ± 1.3 0.9 ± 0.9 0.8 ± 1.0 2.7 ± 2.8 0.3 ± 0.4 0.1 ± 0.3 96.7 ± 78.4
1.5 ± 1.6 0.9 ± 0.8 0.4 ± 0.7 0.2 ± 0.4 1.9 ± 1.5 0.2 ± 0.4 0.1 ± 0.3 68.4 ± 65.7
2.9 ± 2.3 2.1 ± 2.0 1.1 ± 1.1 1.1 ± 0.9 3.0 ± 3.1 0.0 ± 0.0 0.0 ± 0.0 172.7 ± 94.7
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nals recorded with TCD during carotid angioplasty
can range from a few35 to a mean of more than 200
per procedure.12 In other experiments we have sub-
jected carotid specimens to repeated angioplasty bal-
lon inflations with large numbers of fragments dis-
lodged after each balloon inflation. Thus, repeated
angioplasty to fully expand the stent or deploy addi-
tional stents will shed additional emboli. Clearly, there
was no stabilization of the plaque and reduction of
emboli with the deployment of a Palmaz stent.
Because any stent deployment requires fracture of the
plaque to reach its full diameter, it seems unlikely that
stent design will significantly reduce embolization.
Using this experimental protocol, we could only
examine the pathophysiologic importance of plaque
fragments less than 500 µm, because the diameter
of the rat ICA is no more than 1 mm. However,
most of the manipulations also released larger and
presumably much more dangerous fragments.
Although excellent results are reported with carotid
angioplasty,36 there are a few reports of unaccept-
ably high levels of neurologic injury with the proce-
dure.37,38 The reason for these varied results is
undoubtedly multifactorial, but our data suggest
that there is a significant risk of embolization with
carotid angioplasty. Several protective devices have
been designed and are in various stages of testing. If
angioplasty is to be done, one of these innovative
techniques should be used to bring the risk of
periprocedural emboli to as close to zero as 
possible.
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DISCUSSION
Dr Wesley S. Moore, (Los Angeles, Calif). I would like
to congratulate the authors for an experimental study that
is well designed, carefully analyzed, and quite timely.
With the expanding use of carotid balloon angioplasty
and the known potential for atheromatous plaques to
fragment and release embolic particles, we should expect
that there would be an unacceptably high stroke rate from
that procedure. Yet the proponents of angioplasty claim to
have a complication rate that is competitive with carotid
endarterectomy. The authors have addressed this issue by
designing an innovative series of experiments in which
they replicate, ex vivo, the procedure of carotid balloon
angioplasty in actual carotid plaques that were surgically
obtained. The authors have carefully shown that any
maneuver, including guide wire passage, results in the
release of atheroma-emboli. Each balloon inflation and
even a successive inflation with the supposed protection
afforded by stent placement resulted in the release of large
numbers of embolic particles. These particles are variable
in size, so that the next question addressed by the author
was what are the consequences to the brain of these
embolic showers and is there a particle-size threshold for
significant brain damage? Using filtering techniques, the
authors separated out two size categories: particles less
than or equal to 200 µm and particles ranging from 200
to 500 µm. Known concentrations of these particles were
suspended and embolized into the carotid arteries of rats.
Surprisingly, the authors found no evidence of neuronal
damage with the small particle embolization, initially.
However, after 7 days, there was evidence of neuronal
damage. In contrast, embolization with a suspension of
particles in the 200- to 500-µm category did show consis-
tent evidence of neuronal damage. When the brains were
studied histologically, it was remarkable that the effects
were diffuse and there was no evidence for a coalescence
of effect resulting in a gross or discrete area of cerebral
infarction that would correlate with a clinical stroke.
As the authors state in their discussion, “this defies
logic.” As such, we must ask some critical questions before
accepting the conclusion that atheroma-emboli to the
brain is a benign event and therefore an acceptable conse-
quence of carotid balloon angioplasty.
1. Is the internal carotid artery the principal blood supply
to the rat hemisphere? What is the percentage distribu-
tion of blood flow to the rat brain between the carotid
and vertebral circulation?
2. Why did you limit your embolization experiment to
particles no larger than 500 mm when you demon-
strated that particles ranging in size from 500 to 1000
mm and greater did occur in a significant number of
angioplasty specimens? Is it not likely that had you
done experiments with the larger particles you would
have seen discrete infarcts? I would suggest that this
would be a logical extension of your experiment and
thus would have established the actual size threshold
for infarction. Otherwise, what you have shown is that
small particle emboli appear to be well tolerated in this
model, but I hope you will agree that this is not a
model that will predict the results of carotid balloon
angioplasty since the full spectrum (particularly the
larger emboli) have not been tested.
3. Finally, you chose to use heat shock protein 72 as your
marker for neuronal damage. It is my understanding
that protein S-100 has been a standard among neuro-
scientists for this purpose. Would you please comment.
This is an important paper. I enjoyed reading it as well
as hearing the presentation this morning. I look forward
to your reply.
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Dr Joseph Rapp. Yes, the internal carotid artery is the
source of blood flow to the brain in the rat. It is not in some
of the other animal models. Dogs, for example, would be a
poor model for this kind of procedure. In fact, the rat is a
classic experimental model for stroke research. The emboli
injected are commonly bits of thrombus. The curious thing
is that bits of thrombus in the particle range that we inject-
ed actually do cause middle cerebral artery occlusions.
As a hypothesis we suggest that it may be the elongat-
ed shape and flexibility of these patients that allow them to
be well tolerated. In this model they appear to be better
tolerated than particulates of thrombus.
Is it likely that larger particles would cause infarcts?
Well, I think it is. Does in vivo angioplasty actually have the
same particle size as ex vivo angioplasty? Well, there is no
way to know that. My suspicion is it does, and I think we
are then stuck with this conundrum of these embolic frag-
ments that we know can be potentially dangerous being
released and yet apparently having a low rate of stroke.
Now, as Wes himself has mentioned, there are reports
of trials with high rates of stroke with angioplasty, and we
are all looking forward to some very rigorous review of
this technique.
Why HSP72? Because it is a very sensitive marker for
cellular stress/ischemia and the one used by Dr Sharp, our
collaborator.
Dr Dilley (La Jolla, Calif). Joe, I have one question.
Those of us who have looked at transcranial Doppler dur-
ing endarterectomy are always impressed by the number
of seeming particles that go by using that technique.
Do you have a gut feeling as to whether the magni-
tude of the number of particles following an endarterec-
tomy is similar to angioplasty, or do you have any idea
about that?
Dr Rapp. I think there are a couple of articles in stroke
that suggest that endarterectomy does shed fragments,
probably about half the number of angioplasty. 
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